Get started
Author

M Sàbat

Observed names: M Sabat, M Sábat, M. Sabat, M. Sàbat, M. Sâbat, Miriam Sabat, Miriam Sabat Mir, Miriam Sabat-Mir, Miriam Sàbat, Míriam Sàbat
Observed institutions: Universitat Autònoma de Barcelona, German Cancer Research Center, University of Aberdeen, Universitat de Girona, Hospital de Sant Pau, University Hospital, Institut d'Investigació Biomèdica de Girona, Hospital Santa Caterina, Hospital Universitari de Girona Doctor Josep Trueta, Institut d'Assistència Sanitària
ORCID: 0000-0001-7008-7373
Observed ORCID: 0000-0001-7008-7373
OpenAlex ID: A5030308842
Alterations in the Abundance and Co-occurrence of Akkermansia muciniphila and Faecalibacterium prausnitzii in the Colonic Mucosa of Inflammatory Bowel Disease Subjects
2018 · Mireia Lopez-Siles, Núria Enrich-Capó, et al. · Frontiers in Cellular and Infection Microbiology · 222
PDF
Continuous Versus Inpatient Prophylaxis of the First Episode of Spontaneous Bacterial Peritonitis With Norfloxacin
1997 · M Novella, R Sola, et al. · Hepatology · 195
PDF
Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes
2014 · Mireia Lopez-Siles, Margarita Martinez-Medina, et al. · International Journal of Medical Microbiology · 192
Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels
1999 · Carlos Guarner, Ricard Solà, et al. · Gastroenterology · 170
PDF
Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients
2000 · Elena Ricart, Germán Soriano, et al. · Journal of Hepatology · 159
Changes in the Abundance of Faecalibacterium prausnitzii Phylogroups I and II in the Intestinal Mucosa of Inflammatory Bowel Disease and Patients with Colorectal Cancer
2015 · Mireia Lopez-Siles, Margarita Martinez-Medina, et al. · Inflammatory Bowel Diseases · 154
Infections Caused By Escherichia Coli Resistant to Norfloxacin in Hospitalized Cirrhotic Patients
1999 · Jordi Ortiz, Maria Carme Vila, et al. · Hepatology · 129
PDF
Somatostatin Treatment and Risk Stratification by Continuous Portal Pressure Monitoring During Acute Variceal Bleeding
2001 · Càndid Villanueva, Jordi Ortiz, et al. · Gastroenterology · 124
Mucosa-Associated Faecalibacterium prausnitzii Phylotype Richness Is Reduced in Patients with Inflammatory Bowel Disease
2015 · Mireia Lopez-Siles, Margarita Martinez-Medina, et al. · Applied and Environmental Microbiology · 121
Somatostatin alone or combined with emergency sclerotherapy in the treatment of acute esophageal variceal bleeding: A prospective randomized trial
1999 · Càndid Villanueva, Jordi Ortiz, et al. · Hepatology · 114
PDF
Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study
2021 · María Chaparro, Ana Garre, et al. · Journal of Clinical Medicine · 105
Anti-tumour Necrosis Factor Treatment with Adalimumab Induces Changes in the Microbiota of Crohn’s Disease
2015 · David Busquets, Teresa Mas-de-Xaxars, et al. · Journal of Crohn s and Colitis · 78
Prevalence, Abundance, and Virulence of Adherent-Invasive Escherichia coli in Ulcerative Colitis, Colorectal Cancer, and Coeliac Disease
2022 · Mireia López-Siles, Carla Camprubí-Font, et al. · Frontiers in Immunology · 42
Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology
2016 · María José Ferri, Marc Saez, et al. · PLoS ONE · 40
PDF
Effect of Subcutaneous Administration of Octreotide on Endogenous Vasoactive Systems and Renal Function in Cirrhotic Patients with Ascites
1998 · Miriam Sabat, Carlos Guarner, et al. · Digestive Diseases and Sciences · 35
Early microbiologic diagnosis of spontaneous bacterial peritonitis with BacT/ALERT
1997 · Jordi Ortiz, Germán Soriano, et al. · Journal of Hepatology · 26
Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding
1998 · Míriam Sàbat, Lillian Kolle, et al. · The American Journal of Gastroenterology · 25
EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain
2019 · María Chaparro, Manuel Barreiro-de Acosta, et al. · Therapeutic Advances in Gastroenterology · 24
RAID Prediction: Pilot Study of Fecal Microbial Signature With Capacity to Predict Response to Anti-TNF Treatment
2021 · David Busquets, Lia Oliver, et al. · Inflammatory Bowel Diseases · 21
PDF
Epidemiological approximation of the enteric manifestation and possible fecal–oral transmission in COVID-19: a preliminary systematic review
2020 · Javier Pamplona, Rubén Solano, et al. · European Journal of Gastroenterology & Hepatology · 19
PDF
Evaluation of bacterial biomarkers to aid in challenging inflammatory bowel diseases diagnostics and subtype classification
2020 · Mireia Lopez-Siles, Xavier Aldeguer, et al. · World Journal of Gastrointestinal Pathophysiology · 17
PDF
Final results of a prospective and randomized trial evaluating endoscopic hemoclip for bleeding peptic ulcer
1998 · M. Sâbat, C. Villanueva, et al. · Gastroenterology · 15
PDF
Impact of bread diet on intestinal dysbiosis and irritable bowel syndrome symptoms in quiescent ulcerative colitis: A pilot study
2024 · Aleix Lluansí, Marc Llirós, et al. · PLoS ONE · 10
In vitro Prebiotic Effect of Bread-Making Process in Inflammatory Bowel Disease Microbiome
2021 · Aleix Lluansí, Marc Llirós, et al. · Frontiers in Microbiology · 10
A novel distinctive form of identification for differential diagnosis of irritable bowel syndrome, inflammatory bowel disease, and healthy controls
2020 · Sara Ramió‐Pujol, Joan Amoedo, et al. · GastroHep · 6
PDF
Works count: 46
Citation count: 2,080
H-index: 19
I10-index: 24
Year
Topic
Type